Association of Fibronectin with hypogalactosylated immunoglobulin G in gingival crevicular fluid in periodontitis

Journal of Periodontology

Volumn 81, Issue 10, 2010, Pages 1472-1480

  Brajović, Gavrilo ^a   Stefanović, Gordana ^a   Ilić, Vesna ^a   Petrović, Sonja ^a   Stefanović, Neda ^a   Nikolić Jakoba, Nataša ^a   Miloševic Jovcić, Nadežda ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Fibronectin; Glycosylation; Immunoglobulin G; Periodontitis

Indexed keywords

FIBRONECTIN; GALACTOSE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; ANAEROBIC BACTERIUM; ARTICLE; BIOSYNTHESIS; CASE CONTROL STUDY; FEMALE; GINGIVITIS; GLYCOSYLATION; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PERIODONTITIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; STATISTICAL MODEL; TOOTH PLAQUE;

ADULT; BACTERIA, ANAEROBIC; CASE-CONTROL STUDIES; DENTAL PLAQUE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FIBRONECTINS; GALACTOSE; GINGIVAL CREVICULAR FLUID; GLYCOSYLATION; GRAM-NEGATIVE BACTERIA; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; LINEAR MODELS; MALE; MIDDLE AGED; PERIODONTITIS; YOUNG ADULT;

EID: 78249289636     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100053     Document Type: Article

References (35)

1. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38:135-187.
2. Schenkein HA. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol 2000 2006;40:77-93.
3. O'Brien-Simpson NM, Veith PD, Dashper SG, Reynolds EC. Antigens of bacteria associated with periodontitis. Periodontol 2000 2004;35:101-134.
4. Teng Y-TA. Protective and destructive immunity in the periodontium: Part 1-Innate and humoral immunity and the periodontium. J Dent Res 2006;85:198-208.
5. Ebersole JL. Humoral immune responses in gingival crevice fluid: Local and systemic implications. Periodontol 2000 2003;31:135-166.
6. Novak J, Tomana M, Shah GR, Brown R, Mestecky J. Heterogeneity of IgG glycosylation in adult periodontal disease. J Dent Res 2005;84:897-901.
7. Stefanović G, Marković D, Ilić V, Brajović G, Petrović S, Milosević-Jovcić N. Hypogalactosylation of salivary and gingival fluid immunoglobulin G in patients with advanced periodontitis. J Periodontol 2006;77:1887-1893.
8. Arrol H, Jefferis R. Antibody and protein glycosylation in health and disease. In: Lukić M, Čolić M, Mostarica-Stojković M, Čuperlović K, eds. Immunoregulation in Health and Disease. Experimental and Clinical Aspects. New York: Academic Press; 1997:115-138.
9. Krotkiewski H. Carbohydrate moiety of immunoglobulins in health and pathology. Acta Biochim Pol 1999;46:341-350.
10. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995;1:237-243.
11. Salvarrey M, Rostagno A. Affinity of fibronectin for polyclonal IgG. Clin Exp Immunol 1989;76:92-96.
12. Rostagno AA, Frangione B, Gold LI. Biochemical characterization of the fibronectin binding sites for IgG. J Immunol 1989;143:3277-3282.
13. Rostagno AA, Frangione B, Gold LI. Biochemical studies on the interaction of fibronectin with Ig. J Immunol 1991;146:2687-2693.
14. Rostagno A, Williams M, Frangione B, Gold LI. Biochemical analysis of the interaction of fibronectin with IgG and localization of the respective binding sites. Mol Immunol 1996;33:561-572.
15. Hautanen A, Keski-Oja J. Affinity of myeloma IgG proteins for fibronectin. Clin Exp Immunol 1983;53:233-238.
16. Carter SD, Scott DL, Elson CJ. Fibronectin binding with immunoglobulin aggregates and its association with rheumatic disorders. Br J Rheumatol 1986;25:353-358.
17. Cederholm B, Wieslander J, Hygreen P, Heingard D. Circulating complexes containing IgA and fibronectin in patients with primary IgA nephropathy. Proc Natl Acad Sci U S A 1988;85:4865-4868.
18. Kokubo T, Hiki Y, Iwase H, et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J Am Soc Nephrol 1998;9:2048-2054.
19. Waga S, Sugimoto K, Tanaka H, et al. IgA interaction with carboxy-terminal 43-kD fragment of fibronectin in IgA nephropathy. J Am Soc Nephrol 1999;10:256-263.
20. Talonpoika J, Heino J, Larjava H, Häkkinen L, Paunio K. Gingival crevicular fluid fibronectin degradation in periodontal health and disease. Scand J Dent Res 1989;97:415-421.
21. Talonpoika JT, Söderling E, Paunio K. Characterization of fibronectin and fibrin (ogen) fragments in gingival crevicular fluid. Scand J Dent Res 1993;101:26-32.
22. Huynh QN, Wang SH, Tafolla E, et al. Specific fibronectin fragments as markers of periodontal disease status. J Periodontol 2002;73:1101-1110.
23. Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967;38:610-616.
24. Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996;11:266-273.
25. Sumar N, Bodman KB, Rademacher TW, et al. Analysis of glycosylation changes in IgG using lectins. J Immunol Methods 1990;131:127-136.
26. Leader KA, Lastra GC, Kirwan JR, Elson CJ. Agalactosyl IgG in aggregates from the rheumatoid joint. Br J Rheumatol 1996;35:335-341.
27. Cosio FG, Bakaletz AP. Binding of human fibronectin to antigen-antibody complexes. J Lab Clin Med 1986;107:453-458.
28. Turner DW, Pederson ED, Lamberts BL. A sensitive method for the detection of immune complexes in human gingival crevicular fluid. J Clin Periodontol 1992;19:601-603.
29. Kinane DF, Mooney J, MacFarlane TW, McDonald M. Local and systemic antibody response to putative periodontopathogens in patients with chronic periodontitis: Correlation with clinical indices. Oral Microbiol Immunol 1993;8:65-68.
30. Lopatin DE, Caffesse ER, Bye FL, Caffesse RG. Concentrations of fibronectin in the sera and crevicular fluid in various stages of periodontal disease. J Clin Periodontol 1989;16:359-364.
31. Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol 2003;325:979-989.
32. Kuroki A, Kuroda Y, Kikuchi S, et al. Level of galactosylation determines cryoglobulin activity of murine IgG3 monoclonal rheumatoid factor. Blood 2002;99:2922-2928.
33. Thompson SJ, Leader KA, Lastra GC, Elson CJ. The role of agalactosyl IgG in rodent models of autoimmune disease and in pathogenesis of rheumatoid arthritis. In: Isenberg DA, Rademacher TW, Roitt I, eds. Abnormalities of IgG Glycosylation and Immunological Disorders. Chichester: John Wiley & Sons; 1996:131-146.
34. Odani H, Hiki Y, Takahashi M, et al. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem Biophys Res Commun 2000;271:268-274.
35. Newkirk MM, Rauch J. Binding of human monoclonal IgG rheumatoid factors to Fc is influenced by carbohydrate. J Rheumatol 1993;20:776-780.